MAMohammad Ansari

Mohammad Ansari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohammad Ansari has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Solaleh Emamgholipour

    Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    3 shared publications
  • Arash Hossein-Nezhad

    Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran; Department of Medicine, Section of Endocrinology, Nutrition, and Diabetes, Vitamin D, Skin and Bone Research Laboratory, Boston University Medical Center, Boston, Massachusetts, United States

    2 shared publications
  • A. Nowrouzi

    Department of Biochemistry, School of Medicine

    1 shared publication
  • Azam Karkhaneh

    Univ Tehran Med Sci, Sch Med, Dept Biochem, Tehran, Iran

    1 shared publication
  • Fatemeh Askarisadr

    Shahid Beheshti University of Medical Sciences, Tehran, Iran

    1 shared publication
  • Kh Rafiee

    Department of Biochemistry, School of Medicine

    1 shared publication

Latest Publications

  • Open Access

    Can Melatonin Act as an Antioxidant in Hydrogen Peroxide-Induced Oxidative Stress Model in Human Peripheral Blood Mononuclear Cells?

    by Solaleh Emamgholipour, Arash Hossein-Nezhad, Mohammad Ansari

    Purpose.We aimed to investigate the possible effects of melatonin on gene expressions and activities of MnSOD and catalase under conditions of oxidative stress induced by hydrogen peroxide (H2O2) in peripheral blood mononuclear cells (PBMCs).Materials and Methods.PBMCs were isolated from healthy subjects and treated as follows: (1) control (only with 0.1% DMSO for 12 h); (2) melatonin (1 mM) for 12 h; (3) H2O2(250 μM) for 2 h; (4) H2O2(250 μM) for 2 h following 10 h pretreatment with melatonin (1 mM). The gene expression was evaluated by real-time PCR. MnSOD and catalase activities in PBMCs were determined by colorimetric assays.Results.Pretreatment of PBMCs with melatonin significantly augmented expression and activity of MnSOD which were diminished by H2O2. Melatonin treatment of PBMCs caused a significant upregulation of catalase by almost 2-fold in comparison with untreated cells. However, activity and expression of catalase increased by 1.5-fold in PBMCs under H2O2-induced oxidative stress compared with untreated cell. Moreover, pretreatment of PBMCs with melatonin resulted in a significant 1.8-fold increase in catalase expression compared to PBMCs treated only with H2O2.Conclusion.It seems that melatonin could prevent from undesirable impacts of H2O2-induced oxidative stress on MnSOD downregulation. Moreover, melatonin could promote inductive effect of H2O2on catalase mRNA expression.


  • Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes

    by Solaleh Emamgholipour, Arash Hossein-Nezhad, Mohammad Ali Sahraian, Fatemeh Askarisadr, Mohammad Ansari


    • 1 September 2015
      • Vol. 18  (9) , 894-901
    Open Access

    The effect of 17β-estradiol on gene expression of calcitonin gene-related peptide and some pro-inflammatory mediators in peripheral blood mononuclear cells from patients with pure menstrual migraine

    by Azam Karkhaneh, Mohammad Ansari, Solaleh Emamgholipour, Mohammad Hessam Rafiee

    Objective(s): The neuropeptide calcitonin gene-related peptide (CGRP) has long been postulated to play an integral role in the pathophysiology of migraine. Earlier studies showed that CGRP can stimulate the synthesis and release of nitric oxide (NO) and cytokines from trigeminal ganglion glial cells. The purpose of this study was to determine the effect of 17 beta-estradiol in regulation of CGRP expression, inducible nitric oxide synthase (iNOS) activity, and NO and interleukin-1beta (IL-1 beta) release in cultured peripheral blood mononuclear cells (PBMCs) from patients with pure menstrual migraine and healthy individuals. Materials and Methods: This study was performed on twelve patients with pure menstrual migraine and twelve age-and sex-matched healthy individuals. PBMCs treated with 17 beta-estradiol for 24 hr at physiological and pharmacological doses. Gene expression was evaluated by real time-PCR. CGRP and IL-1 beta proteins in culture supernatant were determined by ELISA method. Activity of iNOS in PBMCs and total nitrite in the culture supernatant were measured by colorimetric assays. Results: Treatment with 17 beta-estradiol had a biphasic effect on expression of CGRP. We found that 17 beta-estradiol treatment at pharmacological dose significantly increases mRNA expression of CGRP in both groups (P<0.001), whereas at physiological dose it could significantly decrease CGRP mRNA expression (P<0.001), CGRP protein levels, IL-1 beta release, NO production and iNOS activity only in patient groups (P<0.05). Conclusion: Collectively, it appears that 17 beta-estradiol can exert protective effect on decrease of inflammation in migraine via decrease in levels of CGRP, IL-1 beta and iNOS activity; however, more studies are necessary in this regard.


    • 1 June 2010
      • Vol. 18  (3) , 173-178
    Open Access

    Measurement of melatonin in alcoholic and hot water extracts of Tanacetum parthenium, Tripleurospermum disciforme and Viola odorata

    by M. Ansari, Kh Rafiee, N. Yasa, S. Vardasbi, S. M. Naimi, A. Nowrouzi

    Background and the purpose of the study: Melatonin has recently been found in several plant tissues. Some reports show that the majority of the herbs containing the high level of melatonin have been used traditionally to treat neurological disorders or diseases associated with the generation of free radicals. Current study was undertaken to screen some medicinal plant species with historical evidence of efficacy in the treatment of neurological and antioxidant deficiency related disorders for their melatonin content. The melatonin content of boiled and alcoholic extracts were also compared. Methods: In this study, three medicinal herbs, Tanacetum parthenium (L.) Schultz. Bip. (Asteraceae), Tripleurospermum disciforme (C.A.Mey) Schultz. Bip. (Asteraceae) and Viola odorata (L.) (Violaceae) were analyzed using high performance liquid chromatography with ultraviolet detector (HPLC-UV), enzyme linked immunosorbent assay (ELISA) and thin layer chromatography (TLC). Results: Melatonin content in the dry plant powders differed with different assay methods (p < 0.001). For example, the melatonin content in T disciforme was determined as 3.073 mu g/g and 2.906 mu g/g by the HPLC and the ELISA methods, respectively. Major conclusion: The results demonstrated that a hydroalcoholic solution could extract more melatonin from flowers of the herbs than hot water (p < 0.001). The presence of melatonin in these plant tissues may provide some explanation for the anecdotal evidence of their physiological effects in humans.